iM3 Catalogue - Europe - Flipbook - Page 74
ORALVIVE
TM
Physical barrier gel for topical application to teeth and gums
Cat. Code
GSP001A
OralVive is a 0.8% hyaluronic acid gel formulation (pH 6.5 – 7.5) supplied as 3ml of gel in a 3ml
pre-昀椀lled capped luer-lock syringe with 4 separate applicator tips per pack.
Hyaluronic acid (HA) is a naturally occurring biomaterial that has been proven safe and effective in both humans and
dogs for a variety of indications, including dentistry.
Dental applications of HA have shown statistically
signi昀椀cant ef昀椀cacy in 5+ canine studies and 100+
human studies.
OralVive consists of a pre-昀椀lled tissue applicator
containing HA for convenient and precise delivery to
tissues.
1 syringe + 4 spare tips for application are included.
Simple to use.
OralVive contains fewer synthetic agents and no
dyes, making it gentle on sensitive oral tissues.
Results (3 months)
2
Absolute change (mm or mm)
Restoration relative to defect (%)
HA only
m
(m
th
gr
ow
n
ow
ld
nt
a
el
ia
Baseline
ith
Pe
)
)
)
m
m
(m
m
en
t(
m
am
ig
ll
em
en
tu
rc
rio
do
la
el
lu
Ac
el
ia
ith
HA / ADMA
Establish microbial barrier to support tissue
healing and recovery.
10 weeks
Control
Tella et al., 2023
AUTHOR AND YEAR
INDICATION
Tella et al., 2023
Class II furcations
Shirakata et al., 2022
Class III furcations
Shirakata et al., 2021
Gingival recessions
Shirakata et al., 2021
Two-wall intrabony defects
Kim et al., 2016
Infected extraction sockets
Coronally
Advanced
Flap
Coronally
Advanced
Flap
+
Hyaluronic
Acid
All studies conducted via split-mouth design (i.e. self-control)
Page 74
2 weeks
Ep
)
m
(m
m2
)
ea
ar
he
ig
ne
Bo
ld
Bo
ne
th
ht
(m
(m
m
(m
gr
ow
ow
n
lig
al
nt
Stabilize blood clotting.
)
)
m
m
)
en
t
(m
am
um
Support normal cellular in昀椀ltration.
Ep
la
do
io
lu
el
Ac
Pe
r
Bo
rc
em
ne
en
t
ar
ig
ea
ht
(m
(m
m2
)
m
)
100
90
80
70
60
50
40
30
20
10
0
he
ne
Bo
CO N S U M A B L E S
10
9
8
7
6
5
4
3
2
1
0
Hyaluronic acid works to improve tissue recovery
via multiple mechanisms of action, including:
www.im3vet.eu
Shirakata et al., 2021
